At 28 days post tumor inoculation, we found enhanced numbers of macrophages, monocytes and neutrophils in the spleen and tumor (Figure 1d and e), as well as an increased proportion of cDC1 compared to cDC2 populations upon CD47 × PD‐L1 BisAb therapy (Supplementary figure 3a and b), as previously reported.16 The gene discussed is CD47; the disease is neoplasm.